Cargando…
Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy
Clear Cell Sarcoma (CCS), also referred to as malignant melanoma of soft parts, is a rare and aggressive malignant tumor. It comprises 1% of all soft tissue sarcomas and is known to be radio- and chemotherapy resistant. CCS shares morphological and immunohistochemical features with malignant melanom...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582433/ https://www.ncbi.nlm.nih.gov/pubmed/36275056 http://dx.doi.org/10.3389/fped.2022.940927 |